Free Trial
LON:SAR

Sareum (SAR) Share Price, News & Analysis

Sareum logo
GBX 25.50
+0.50 (+2.00%)
(As of 11/1/2024 ET)

About Sareum Stock (LON:SAR)

Key Stats

Today's Range
24.60
26
50-Day Range
23.41
31
52-Week Range
10
78
Volume
138,146 shs
Average Volume
722,476 shs
Market Capitalization
£27.53 million
P/E Ratio
N/A
Dividend Yield
1.10%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases. Its also developing SDC-1802, a TYK2/JAK1 inhibitor, which is in preclinical stage for cancerandcancer-immunotherapy applications; and SRA737, a clinical-stage, oral, selective Checkpoint kinase 1 (Chk1) inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.

Receive SAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter.

SAR Stock News Headlines

Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
Sareum Share Chat (SAR)
See More Headlines

SAR Stock Analysis - Frequently Asked Questions

Sareum's stock was trading at GBX 59.50 at the beginning of 2024. Since then, SAR shares have decreased by 57.1% and is now trading at GBX 25.50.
View the best growth stocks for 2024 here
.

Shares of SAR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP) and Summit Therapeutics (SMMT).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Financial Services
CIK
N/A
Fax
N/A
Employees
3,211
Year Founded
N/A

Profitability

Net Income
£-4,250,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£47,204.00
Cash Flow
GBX 2.25 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£27.53 million
Optionable
Not Optionable
Beta
-1.08
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (LON:SAR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners